Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable.

P J Casterella1, D J Kereiakes, S R Steinhubl

  • 1Division of Cardiovascular Disease, Scripps Clinic, La Jolla, California, USA. pjc151@home.com

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|December 18, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of 6% hydroxyethyl starch 130/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial.

Anaesthesia·2020
Same author

Diagnostic approach to microangiopathic hemolytic disorders.

International journal of laboratory hematology·2017
Same author

Validation of a panel of ADAMTS13 assays for diagnosis of thrombotic thrombocytopenic purpura: activity, functional inhibitor, and autoantibody test.

International journal of laboratory hematology·2016
Same author

Cardiac transplant-associated vascular disease: Evolution, immunophenotype, and evidence of endothelial activation.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Extracardiac thrombotic, embolic, and hemorrhagic causes of sudden death.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Safety and efficacy of protease-activated receptor-1 antagonists in patients with coronary artery disease: a meta-analysis of randomized clinical trials.

Journal of thrombosis and haemostasis : JTH·2012

This study found significant variability in how patients respond to abciximab during percutaneous coronary intervention (PCI). Many patients achieve effective platelet inhibition with less than the standard dose, suggesting personalized dosing may be beneficial.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hematology

Background:

  • Platelet aggregation is crucial in percutaneous coronary intervention (PCI).
  • Abciximab is an antiplatelet medication used during PCI to prevent thrombotic complications.
  • Optimizing abciximab dosing is essential for patient outcomes.

Purpose of the Study:

  • To evaluate the dose-response relationship of abciximab on platelet function in patients undergoing PCI.
  • To identify the percentage of patients achieving adequate platelet inhibition at different abciximab dose levels.

Main Methods:

  • A point-of-service platelet function assay was used in 85 patients.
  • Patients received incremental bolus doses of abciximab during PCI.
  • Platelet function was measured at 10-minute intervals during incremental dosing.

Related Experiment Videos

Main Results:

  • 40% of patients achieved >= 80% platelet inhibition with 50% of a standard abciximab bolus.
  • 87% of patients achieved >= 80% platelet inhibition with 75% of a standard abciximab bolus.
  • 95% of patients achieved >= 80% platelet inhibition with 100% of a standard abciximab bolus.
  • No significant associations were found between dose-response and patient factors like age, weight, or comorbidities.

Conclusions:

  • Significant interpatient variability exists in platelet function response to abciximab.
  • A substantial proportion of patients achieve high-level platelet inhibition with less than the standard abciximab dose.
  • These findings suggest potential for individualized abciximab dosing strategies in PCI.